Nanotechnology Tools for Infection Control: Scanning New Horizons on Next-Generation Therapies to Eradicate Pathogens and Fight Drug Resistance

About

Alessandro Poma received his MSc in Pharmaceutical Technology and Chemistry from the University of Palermo (Italy) in 2009. He then joined the Cranfield Biotechnology Group led by Prof. Sergey Piletsky to undertake a PhD in Biosensors and Nanomaterials (Cranfield University 2013). He moved to UCL in 2014 first as an NC3Rs David Sainsbury Fellow and subsequently in other roles and he has been appointed Lecturer in Biomaterials and Allied Subjects in the Division of Biomaterials and Tissue Engineering in 2019. His key research area is the development of molecularly imprinted nanomaterials as synthetic antibodies and their polymeric biodegradable composites for diagnostic therapeutic and tissue engineering applications Loris Rizzello received his MSc (Magna cum Laude) in Biotechnology at the University of Salento (Italy) in 2008 and the PhD in nanoscience at the Italian institute of Technology (IIT) in 2012. He then joined the University College London (UCL) Department of Chemistry as International Newton Postdoctoral Fellow (by The Royal Society) under the supervision of Prof. Giuseppe Battaglia. He moved to the Institute for Bioengineering of Catalonia (IBEC) of Barcelona as a Marie Curie Fellow in 2018. He has been appointed as Associate Professor of Protein Engineering and ERC-StG grantee at the University of Milan Department of Pharmaceutical Science since October 2020. From March 2021 he is also Junior Group Leader at National Institute of Molecular Genetics of Milan (INGM) where he leads the Infection Dynamics Laboratory. His key research area is the use of cell-derived biomimetic nanoparticles for the treatment of intracellular pathogens infections with a focus on the eradication of human tuberculosis. He also investigates the innate and adaptive immune response to Mycobacteria infections.